Published in Science on February 17, 1989
Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. J Virol (1989) 4.60
Expression of virus-encoded proteinases: functional and structural similarities with cellular enzymes. Microbiol Rev (1993) 3.33
Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. J Virol (1991) 2.38
Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J Virol (1991) 2.23
An aspartyl protease directs malaria effector proteins to the host cell. Nature (2010) 1.92
Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J Exp Med (1991) 1.80
SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling. Nat Protoc (2008) 1.79
Protein model structure evaluation using the solvation free energy of folding. Proc Natl Acad Sci U S A (1990) 1.38
Effect of linker insertion mutations in the human immunodeficiency virus type 1 gag gene on activation of viral protease expressed in bacteria. J Virol (1993) 1.37
Proteases from human immunodeficiency virus and avian myeloblastosis virus show distinct specificities in hydrolysis of multidomain protein substrates. J Virol (1990) 1.33
Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Curr HIV Res (2010) 1.29
Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase. J Virol (1990) 1.19
Cauliflower mosaic virus produces an aspartic proteinase to cleave its polyproteins. EMBO J (1989) 1.10
Biomolecularmodeling and simulation: a field coming of age. Q Rev Biophys (2011) 1.06
Molecular mechanisms of FIV infection. Vet Immunol Immunopathol (2008) 1.02
Three-dimensional structural model of the serine receptor ligand-binding domain. Protein Sci (1993) 0.97
Knowledge-based model building of proteins: concepts and examples. Protein Sci (1993) 0.96
A model of tripeptidyl-peptidase I (CLN2), a ubiquitous and highly conserved member of the sedolisin family of serine-carboxyl peptidases. BMC Struct Biol (2003) 0.81
Structural studies on molecular mechanisms of Nelfinavir resistance caused by non-active site mutation V77I in HIV-1 protease. BMC Bioinformatics (2015) 0.80
Carbamylation of N-terminal proline. ACS Med Chem Lett (2010) 0.80
The early years of retroviral protease crystal structures. Biopolymers (2010) 0.79
Segmental aneuploidy and the genetic gross structure of the Drosophila genome. Genetics (1972) 22.68
The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell (1990) 7.19
Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science (1989) 7.15
The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J Virol (1989) 6.83
Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol (1992) 6.77
Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol (1988) 6.31
An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol (1994) 5.87
Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A (2001) 5.83
Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol (1978) 5.22
Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA (1999) 4.71
EXPERIMENTAL HYPOSTHENURIA. J Clin Invest (1939) 4.64
Retroviral integrase domains: DNA binding and the recognition of LTR sequences. Nucleic Acids Res (1991) 4.39
The retroviral enzymes. Annu Rev Biochem (1994) 4.21
Inventory of Complicated Grief: a scale to measure maladaptive symptoms of loss. Psychiatry Res (1995) 4.17
Structure of bovine pancreatic trypsin inhibitor. Results of joint neutron and X-ray refinement of crystal form II. J Mol Biol (1984) 4.14
Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol (1996) 3.97
A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging. J Virol (1986) 3.95
Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements. Cell (1980) 3.53
A formalin-inactivated whole SIV vaccine confers protection in macaques. Science (1989) 3.37
Diabetes mellitus in American (Pima) Indians. Lancet (1971) 3.30
Control of retroviral RNA splicing through maintenance of suboptimal processing signals. Mol Cell Biol (1990) 3.18
The relation between baseline HIV drug resistance and response to antiretroviral therapy: re-analysis of retrospective and prospective studies using a standardized data analysis plan. Antivir Ther (2000) 3.14
Isolation and characterization of an endonuclease from Escherichia coli specific for ribonucleic acid in ribonucleic acid-deoxyribonucleic acid hybrid structures. J Biol Chem (1973) 3.13
Nucleotide sequence of acceptor site and termini of integrated avian endogenous provirus ev1: integration creates a 6 bp repeat of host DNA. Cell (1981) 3.10
HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science (1986) 3.06
Interaction between retroviral U5 RNA and the T psi C loop of the tRNA(Trp) primer is required for efficient initiation of reverse transcription. J Virol (1992) 3.06
Catalytic triads and their relatives. Trends Biochem Sci (1998) 3.06
Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A (2001) 3.04
Novel mutations of the MET proto-oncogene in papillary renal carcinomas. Oncogene (1999) 3.01
Partitioning of C-photosynthate, and long distance translocation of amino acids in preflowering and flowering, nodulated and nonnodulated soybeans. Plant Physiol (1979) 2.99
Postaxial acrofacial dysostosis syndrome. J Pediatr (1979) 2.93
Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep (2000) 2.90
Phase i/ii trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults. Antimicrob Agents Chemother (2001) 2.84
The structural basis for spectral variations in green fluorescent protein. Nat Struct Biol (1997) 2.79
Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution. Science (1989) 2.74
Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature (1989) 2.72
Nucleotide sequence of noncoding regions in Rous-associated virus-2: comparisons delineate conserved regions important in replication and oncogenesis. J Virol (1984) 2.71
A role for DNA-PK in retroviral DNA integration. Science (1999) 2.68
Avian sarcoma and leukosis virus pol-endonuclease recognition of the tandem long terminal repeat junction: minimum site required for cleavage is also required for viral growth. J Virol (1987) 2.62
A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J Virol (1988) 2.62
The role of branchpoint and 3'-exon sequences in the control of balanced splicing of avian retrovirus RNA. Genes Dev (1991) 2.58
Generation of diversity in retroviruses. Annu Rev Genet (1990) 2.53
Site-directed mutagenesis using overlap extension PCR. Methods Mol Biol (1996) 2.49
Retroviral integrase functions as a multimer and can turn over catalytically. J Biol Chem (1992) 2.48
New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor. Nature (1991) 2.47
Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat Biotechnol (2001) 2.46
Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. I. Kinetics of synthesis and size of minus- and plus-strand transcripts. J Virol (1981) 2.45
Selective cleavage in the avian retroviral long terminal repeat sequence by the endonuclease associated with the alpha beta form of avian reverse transcriptase. Proc Natl Acad Sci U S A (1983) 2.40
Retroviral DNA H structures: displacement-assimilation model of recombination. Cell (1982) 2.37
Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. JAMA (1999) 2.36
Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression. J Virol (1991) 2.26
Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res (1980) 2.25
Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp 12. Mutation which affects RNA binding in vitro blocks viral replication. J Biol Chem (1988) 2.25
Association between mortality among women and socioeconomic factors in general practices in Edinburgh: an application of small area statistics. Br Med J (Clin Res Ed) (1987) 2.22
Outbreak of Pontiac fever due to Legionella anisa. Lancet (1990) 2.20
Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction (2001) 2.17
High-resolution structure of the catalytic domain of avian sarcoma virus integrase. J Mol Biol (1995) 2.16
Overlapping retrovirus U5 sequence elements are required for efficient integration and initiation of reverse transcription. J Virol (1991) 2.16
Isolation and characterization of recombinant DNA clones of avian retroviruses: size heterogeneity and instability of the direct repeat. J Virol (1980) 2.15
Hydroxyproline heterooligosaccharides in Chlamydomonas. Science (1972) 2.12
Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet (1993) 2.12
Diuretic action of three sulfonylurea drugs. Ann Intern Med (1973) 2.10
A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J Virol (1994) 2.07
HIV-1 integrase: structural organization, conformational changes, and catalysis. Adv Virus Res (1999) 2.06
Crystallization of nerve growth factor from mouse submaxillary glands. Proc Natl Acad Sci U S A (1975) 2.03
Properties of avian sarcoma-leukosis virus pp32-related pol-endonucleases produced in Escherichia coli. J Virol (1988) 2.03
Modification of the megaprimer method of PCR mutagenesis: improved amplification of the final product. Biotechniques (1993) 2.02
Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med (1970) 2.02
Tuberculosis in the autopsy material: analysis of 1500 autopsies performed between 1972 and 1991 in the Institute of Tuberculosis and Chest Diseases, Warsaw, Poland. Tuber Lung Dis (1995) 2.00
The chemical composition of the cell wall of Chlamydomonas gymnogama and the concept of a plant cell wall protein. J Cell Biol (1974) 1.95
Epidemiologic studies of diabetes in the Pima Indians. Recent Prog Horm Res (1976) 1.95
Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J Immunol (1999) 1.95
Characteristics and regulation of interaction of avian retrovirus pp12 protein with viral RNA. J Virol (1983) 1.94
THE RELATION OF SPECIFIC GRAVITY TO COMPOSITION AND TOTAL SOLIDS IN NORMAL HUMAN URINE. J Clin Invest (1940) 1.92
DNA replication--bacteriophage lambda. Curr Top Microbiol Immunol (1977) 1.92
Are household firearms stored safely? It depends on whom you ask. Pediatrics (2000) 1.91
Atlas vertebra realignment and achievement of arterial pressure goal in hypertensive patients: a pilot study. J Hum Hypertens (2007) 1.91
Endogenous avian retroviruses contain deficient promoter and leader sequences. Proc Natl Acad Sci U S A (1983) 1.90
Sequence comparison in the crossover region of an oncogenic avian retrovirus recombinant and its nononcogenic parent: genetic regions that control growth rate and oncogenic potential. Mol Cell Biol (1982) 1.89
cis-acting intron mutations that affect the efficiency of avian retroviral RNA splicing: implication for mechanisms of control. J Virol (1988) 1.88
Viral DNA synthesized in vitro by avian retrovirus particles permeabilized with melittin. II. Evidence for a strand displacement mechanism in plus-strand synthesis. J Virol (1981) 1.87
Proteolytic processing of avian sarcoma and leukosis viruses pol-endo recombinant proteins reveals another pol gene domain. J Virol (1987) 1.85
Drug-induced dilutional hyponatremia. N Engl J Med (1974) 1.85
Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. Proc Natl Acad Sci U S A (1986) 1.83
Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Support Care Cancer (2008) 1.78